| Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma (NCT03957551) | John Rieth | 2019-08-27 |
| Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma (NCT04097301) | AGC Biologics S.p.A. | 2019-08-27 |
| The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis (NCT04134091) | Lipocine Inc. | 2019-08-27 |
| A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine (NCT04102995) | Asarina Pharma | 2019-08-27 |
| Topical KB105 Gene Therapy for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) (NCT04047732) | Krystal Biotech, Inc. | 2019-08-27 |
| RANKL Inhibition and Mammographic Breast Density (NCT04067726) | Washington University School of Medicine | 2019-08-27 |
| Revaccination With PPS23 Boosted or Not by PCV13 in Splenectomised Patients. (NCT03873727) | Assistance Publique - Hôpitaux de Paris | 2019-08-27 |
| Sublingual Versus Intranasal Administration of Dexmedetomidine for Sedation of Children Undergoing Dental Treatment (NCT04237532) | Nourhan M.Aly | 2019-08-27 |
| A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism (NCT04009291) | Ascendis Pharma A/S | 2019-08-27 |
| ASTX727 and FT-2102 in Treating IDH1-Mutated Recurrent/Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT04013880) | Vanderbilt-Ingram Cancer Center | 2019-08-27 |
| Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ (NCT04061928) | Peking University | 2019-08-26 |
| The Role of Secondary Bile Acids in Intestinal Inflammation (NCT03724175) | Stanford University | 2019-08-26 |
| Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma (NCT04067037) | Henan Cancer Hospital | 2019-08-26 |
| Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation (NCT04123340) | Leiden University Medical Center | 2019-08-26 |
| Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer (NCT03937141) | Chinook Therapeutics, Inc. (formerly Aduro) | 2019-08-26 |
| De-Escalation Therapy for Human Papillomavirus Negative Disease (NCT03944915) | University of Chicago | 2019-08-26 |
| Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants (NCT04088357) | BioMendics, LLC | 2019-08-26 |
| Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence (NCT03897062) | The Florey Institute of Neuroscience and Mental Health | 2019-08-26 |
| Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients. (NCT04053322) | UNICANCER | 2019-08-26 |
| A Study of the Safety, Tolerability and Efficacy of Treatment With AP1189 in Early RA Patients With Active Joint Disease (NCT04004429) | SynAct Pharma Aps | 2019-08-26 |
| Smartphone Based Smoking Cessation Intervention (NCT03740490) | University of Oklahoma | 2019-08-26 |
| Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD (NCT04055883) | Dong-A ST Co., Ltd. | 2019-08-26 |
| Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149 (NCT03997448) | Nataliya Uboha | 2019-08-26 |
| Trial to Evaluate Safety, Tolerability, Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis (NCT04093895) | Geistlich Pharma AG | 2019-08-26 |
| Study of NPO-13 During Colonoscopy (NCT04097574) | Nihon Pharmaceutical Co., Ltd | 2019-08-26 |
| First Line Therapy for High Risk Acute GVHD (NCT04061876) | Chinese PLA General Hospital | 2019-08-25 |
| Articaine Efficacy and Safety for Children Below Age of 4-years (NCT04061265) | Minia University | 2019-08-25 |
| Minocycline Treatment in Retinitis Pigmentosa (NCT04068207) | Sun Yat-sen University | 2019-08-25 |
| Multimodality Intervention for Function and Metabolism in SCI (NCT03576001) | Brigham and Women's Hospital | 2019-08-23 |
| A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) (NCT03824704) | pharmaand GmbH | 2019-08-23 |
| Fecal Microbiota Transplant for Primary CDI (NCT03795233) | Boston Medical Center | 2019-08-23 |
| Improving Self-care of Heart Failure Caregivers (NCT03988621) | University of Pennsylvania | 2019-08-23 |
| Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension (NCT04004000) | Fulcrum Therapeutics | 2019-08-23 |
| Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis (NCT04041856) | Farabi Eye Hospital | 2019-08-23 |
| Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma (NCT04065087) | Genexine, Inc. | 2019-08-22 |
| Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC) (NCT03979131) | Vall d'Hebron Institute of Oncology | 2019-08-22 |
| A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants (NCT03816176) | Astellas Pharma Global Development, Inc. | 2019-08-22 |
| Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant (NCT03924401) | Emory University | 2019-08-22 |
| Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke (NCT03763929) | Diffusion Pharmaceuticals Inc | 2019-08-22 |
| Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D (NCT03841526) | Xeris Pharmaceuticals | 2019-08-22 |
| Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma (NCT04068831) | Memorial Sloan Kettering Cancer Center | 2019-08-22 |
| Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma (NCT03789240) | National Cancer Institute (NCI) | 2019-08-22 |
| Treating Hyperexcitability in AD With Levetiracetam (NCT03875638) | Beth Israel Deaconess Medical Center | 2019-08-22 |
| Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D (NCT04074317) | Xeris Pharmaceuticals | 2019-08-22 |
| Effect of Melatonin and Metformin on Glycemic Control Genotoxicity and Cytotoxicity Markers in Patients With Prediabetes (NCT03848533) | University of Guadalajara | 2019-08-22 |
| Macular Pigment and Visual Performance in Glaucoma Patients (NCT03959592) | Felipe Medeiros, MD | 2019-08-21 |
| Project 4, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Pregnant Women (NCT04033237) | University of Vermont | 2019-08-21 |
| The Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal-Vascular Fraction of Adipose Tissue Cells for Treatment of Knee Joint Arthrosis (NCT04050111) | Swiss Medica XXI Century S.A. | 2019-08-21 |
| the Hypertrophic Scar Prevention of BMT101. (NCT04012099) | Hugel | 2019-08-21 |
| Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure (NCT03879629) | Mayo Clinic | 2019-08-21 |
| Controlling Rapid Atrial Fibrillation With Dexmedetomidine (NCT04042727) | Stony Brook University | 2019-08-21 |
| MRD-guided Treatment in NPM1mut AML Patients (NCT03769532) | Technische Universität Dresden | 2019-08-21 |
| A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (NCT04051944) | UCB Biopharma SRL | 2019-08-21 |
| A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 (NCT03650257) | Cure&Sure Biotech Co., LTD | 2019-08-21 |
| Asymptomatic Congenital CMV Treatment (NCT03301415) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-08-21 |
| Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy (NCT04056299) | Aimmune Therapeutics, Inc. | 2019-08-20 |
| Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia (NCT04076943) | Kyntra Bio | 2019-08-20 |
| Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia (NCT04083014) | Peking Union Medical College Hospital | 2019-08-20 |
| Treatment of PD-1 Inhibitor in AIDS-associated PML (NCT04091932) | First Affiliated Hospital of Zhejiang University | 2019-08-20 |
| Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation (NCT03637556) | DisperSol Technologies, LLC | 2019-08-20 |
| Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors (NCT04060472) | Dong Wang | 2019-08-20 |
| Camrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal Cancer (NCT04067986) | Zhongshan Hospital Xiamen University | 2019-08-20 |
| Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma (NCT04012827) | Sun Yat-sen University | 2019-08-20 |
| Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma (NCT03921073) | H. Lee Moffitt Cancer Center and Research Institute | 2019-08-20 |
| Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC (NCT03994744) | Hunan Cancer Hospital | 2019-08-20 |
| The Effect of Multiple Injection of Platlet-rich Plasma in Chronic Patellar Tendinopathy (NCT03986372) | Chang Gung Memorial Hospital | 2019-08-20 |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML (NCT04061239) | GWT-TUD GmbH | 2019-08-19 |
| Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma (NCT03980171) | Peter MacCallum Cancer Centre, Australia | 2019-08-19 |
| Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation (NCT03963154) | Centre d'Etude des Cellules Souches | 2019-08-19 |
| A Study of RC48-ADC in Subjects With HER2-negative Locally Advanced or Metastatic Urothelial Cancer (NCT04073602) | RemeGen Co., Ltd. | 2019-08-19 |
| Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT) (NCT04716075) | Polish Lymphoma Research Group | 2019-08-19 |
| Frontline Asciminib Combination in Chronic Phase CML (NCT03906292) | University of Jena | 2019-08-19 |
| BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers (NCT04021043) | M.D. Anderson Cancer Center | 2019-08-19 |
| A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants (NCT03929757) | Janssen Vaccines & Prevention B.V. | 2019-08-19 |
| Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin Lymphoma (NCT05660993) | National Research Center for Hematology, Russia | 2019-08-19 |
| A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis (NCT03952637) | National Human Genome Research Institute (NHGRI) | 2019-08-19 |
| A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma (NCT03880019) | National Cancer Institute (NCI) | 2019-08-19 |
| Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis (NCT03749109) | Ferring Pharmaceuticals | 2019-08-19 |
| SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study) (NCT04079166) | Scancell Ltd | 2019-08-19 |
| Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST) (NCT04138381) | Grupo Espanol de Investigacion en Sarcomas | 2019-08-16 |
| Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL) (NCT03953456) | Genfit | 2019-08-16 |
| Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL (NCT03736616) | Swedish Medical Center | 2019-08-16 |
| R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL：a Multicenter Phase Ib/II Stuty (NCT04120350) | Peking Union Medical College Hospital | 2019-08-16 |
| Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis (NCT03949153) | University Hospital, Strasbourg, France | 2019-08-16 |
| An Open Label Phase II Study Combining Nivolumab and Celecoxib in Patients With Advanced " Cold " Solid Tumors (NCT03864575) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2019-08-15 |
| TAS-102 in Extrapulmonary Neuroendocrine Carcinoma (NCT04042714) | Baylor Research Institute | 2019-08-15 |
| Rituximab for HTLV-1-associated Myelopathy (NCT04004819) | First Affiliated Hospital of Fujian Medical University | 2019-08-15 |
| Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia (NCT04119050) | Janssen Research & Development, LLC | 2019-08-15 |
| ATL001 in Patients With Metastatic or Recurrent Melanoma (NCT03997474) | Achilles Therapeutics UK Limited | 2019-08-15 |
| Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization (NCT04065737) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2019-08-15 |
| Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma (NCT04044378) | Peking University People's Hospital | 2019-08-15 |
| The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients (NCT03819322) | Fernanda P Silveira, MD, MS | 2019-08-15 |
| Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma (NCT04049344) | Zhejiang Cancer Hospital | 2019-08-15 |
| MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma (NCT04013334) | Momotaro-Gene Inc. | 2019-08-15 |
| Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases (NCT03870750) | Fred Hutchinson Cancer Center | 2019-08-15 |
| Study to Evaluate the Efficacy and Safety of CDK4/6 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast Cancer (NCT03993964) | Sun Yat-sen University | 2019-08-15 |
| A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor (NCT04254939) | CStone Pharmaceuticals | 2019-08-15 |
| Efficacy of Erector Spinae Plane Block Versus Infraclavicular Subomohyoid Block in Shoulder Surgery (NCT04183244) | Ain Shams University | 2019-08-15 |
| Detection of Cannabis Impairment With an Eye Tracker (NCT03813602) | Centre for Addiction and Mental Health | 2019-08-15 |
| Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma (NCT04046939) | Knopp Biosciences | 2019-08-15 |